{
    "organizations": [],
    "uuid": "66d03acb99233c0fde11369f4c0309b7d4b466d3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-crescita-therapeutics-receives-fir/brief-crescita-therapeutics-receives-first-shipments-of-pliaglis-product-will-be-launched-by-u-s-licensing-partner-idUSFWN1RB0G2",
    "ord_in_thread": 0,
    "title": "Crescita Therapeutics Receives ‍First Shipments Of Pliaglis, Product Will Be Launched By U.S. Licensing Partner​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29 (Reuters) - Crescita Therapeutics Inc:\n* CRESCITA THERAPEUTICS INC - ‍FIRST SHIPMENTS OF PLIAGLIS HAVE NOW BEEN RECEIVED AND PRODUCT WILL BE LAUNCHED BY OUR U.S. LICENSING PARTNER​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-29T20:06:00.000+03:00",
    "crawled": "2018-03-30T13:00:16.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "crescita",
        "therapeutic",
        "inc",
        "crescita",
        "therapeutic",
        "inc",
        "shipment",
        "pliaglis",
        "received",
        "product",
        "launched",
        "licensing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}